A new genome editing strategy can normalize the β-globin:α-globin balance in human hematopoietic stem cells from patients with β-thalassemia and restore functional adult hemoglobin tetramers in patient-derived red blood cells.
- M. Kyle Cromer
- Joab Camarena
- Matthew H. Porteus